532 related articles for article (PubMed ID: 16030067)
1. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
[TBL] [Abstract][Full Text] [Related]
2. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Granado M; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
Granado M; Martín AI; Priego T; López-Calderón A; Villanúa MA
J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
[TBL] [Abstract][Full Text] [Related]
4. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.
Yamamoto D; Ikeshita N; Matsubara T; Tasaki H; Herningtyas EH; Toda K; Iida K; Takahashi Y; Kaji H; Chihara K; Okimura Y
Life Sci; 2008 Feb; 82(9-10):460-6. PubMed ID: 18191156
[TBL] [Abstract][Full Text] [Related]
5. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R541-51. PubMed ID: 20519361
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.
Sheriff S; Joshi R; Friend LA; James JH; Balasubramaniam A
Peptides; 2009 Oct; 30(10):1909-13. PubMed ID: 19577604
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
Castillero E; Nieto-Bona MP; Fernández-Galaz C; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E790-9. PubMed ID: 21304067
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx.
Balasubramaniam A; Joshi R; Su C; Friend LA; Sheriff S; Kagan RJ; James JH
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R893-901. PubMed ID: 19211729
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
11. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
Gomez-Sanmiguel AB; Nieto-Bona MP; Fernandez-Galaz C; Priego T; Martin AI; Lopez-Calderon A
J Physiol Pharmacol; 2017 Apr; 68(2):191-199. PubMed ID: 28614768
[TBL] [Abstract][Full Text] [Related]
13. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
15. [MAFbx and MuRF1 mRNA expression and its relationship with muscular contractility following free muscle transfer].
Liu AT; Yu DZ; Zhang YF; Zhang WJ; Ding WJ; Ren AJ; Fang CP; Jiang H
Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 May; 25(3):217-21. PubMed ID: 19803207
[TBL] [Abstract][Full Text] [Related]
16. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting.
Castillero E; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
Mol Cell Endocrinol; 2009 Oct; 309(1-2):8-16. PubMed ID: 19501629
[TBL] [Abstract][Full Text] [Related]
17. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes.
Dehoux M; Van Beneden R; Pasko N; Lause P; Verniers J; Underwood L; Ketelslegers JM; Thissen JP
Endocrinology; 2004 Nov; 145(11):4806-12. PubMed ID: 15284206
[TBL] [Abstract][Full Text] [Related]
18. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K
Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276
[TBL] [Abstract][Full Text] [Related]
20. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis.
Krawiec BJ; Frost RA; Vary TC; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E969-80. PubMed ID: 16046454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
